Skip to main content
logo
Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.1900
+0.0200 (11.76%)
Jul 8, 2025, 9:30 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Molecular Testing Products
4.00K
Log In
Log In
Log In
Log In
Upgrade
Molecular Testing Products Growth
-98.69%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
United States
4.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-98.69%
Log In
Log In
Log In
Log In
Upgrade